Evidence map›Paper›PMID 39165904›Full record

ArticleFrontiers in human neuroscience2024

Open Brain AI and language assessment.

Charalambos Themistocleous

Abstract read
In one paragraph

Article in Frontiers in human neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Charalambos ThemistocleousDepartment of Special Needs Education, Helga Engs Hus, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurolinguistic assessments play a vital role in neurological examinations, revealing a wide range of language and communication impairments associated with developmental disorders and acquired neurological conditions. Yet, a thorough neurolinguistic assessment is time-consuming and laborious and takes valuable resources from other tasks. To empower clinicians, healthcare providers, and researchers, we have developed Open Brain AI (OBAI). The aim of this computational platform is twofold. First, it aims to provide advanced AI tools to facilitate spoken and written language analysis, automate the analysis process, and reduce the workload associated with time-consuming tasks. The platform currently incorporates multilingual tools for English, Danish, Dutch, Finnish, French, German, Greek, Italian, Norwegian, Polish, Portuguese, Romanian, Russian, Spanish, and Swedish. The tools involve models for (i) audio transcription, (ii) automatic translation, (iii) grammar error correction, (iv) transcription to the International Phonetic Alphabet, (v) readability scoring, (vi) phonology, morphology, syntax, semantic measures (e.g., counts and proportions), and lexical measures. Second, it aims to support clinicians in conducting their research and automating everyday tasks with "OBAI Companion," an AI language assistant that facilitates language processing, such as structuring, summarizing, and editing texts. OBAI also provides tools for automating spelling and phonology scoring. This paper reviews OBAI's underlying architectures and applications and shows how OBAI can help professionals focus on higher-value activities, such as therapeutic interventions.

Indexed as

clinical AI analysiscognitionlanguagenatural language processing (NLP)Open Brain AI

Identifiers

PMID39165904
PMCPMC11333242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.